Latest Research And Development News

Talius Group has reported its second consecutive quarter of positive operating cash flow, alongside an 11% annual increase in subscriptions and a $1.81 million revenue haul for Q1 FY26. The appointment of Pat Howard as CEO and a new $567k contract with Seventh-Day Adventist Aged Care signal momentum in the company’s push toward scalable growth.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

Connexion Mobility reported a record $3 million quarterly revenue, boosted by exclusive software deployment for GM Canada’s Enhanced Exposure Program, while net profit before tax fell 31% due to higher expenses.

Marquee Resources (ASX:MQR) has secured a non-exclusive R&D patent licence with Oak Ridge National Laboratory, granting access to NEAREST technology tailored for clay-rich rare earth deposits like Redlings in WA. This partnership could reshape processing efficiency and environmental impact for Marquee’s significant inferred resource.

Truscott Mining’s maiden 2026 drilling at Westminster confirms shear-hosted gold mineralisation and sets the stage for diamond drilling and resource upgrades. Management changes and mining lease applications signal a push towards production.

Legend Mining has identified significant chargeable-resistive features at its Pinnacle Well Project, enhancing gold prospectivity at Alpha North and Pyrophyllite Hill. The company is progressing drill approvals aiming for a July start, supported by a solid $10.2 million cash balance.

EMVision Medical Devices has ramped up recruitment in its pivotal FDA trial across eight hospitals and is nearing results from multiple pre-hospital studies, all while bolstering its cash position with a $3.8 million R&D tax refund and $6.6 million in grant funding.

Ainsworth Game Technology Limited has released its Target’s Statement recommending shareholders accept an unconditional proportional off-market takeover bid by Mr Kjerulf David Hastings Ainsworth at $1.30 per share, representing a premium to recent trading prices.

Marquee Resources has entered a 24-month patent license and option agreement with UT-Battelle LLC, granting access to advanced rare earth element separation technologies from Oak Ridge National Laboratory. This positions Marquee to explore downstream processing opportunities for its Redlings REE Project in Western Australia.

Wide Open Agriculture Ltd (ASX: WOA) has received a A$1,686,579 R&D tax rebate for the 2024-25 financial year, reflecting its significant innovation efforts in lupin protein development across Australia and Germany. The rebate will support the company’s commercialisation and growth initiatives.

Vitrafy Life Sciences has announced the completion of Phase II testing of a platelet cryopreservation study with the U.S. Army Institute of Surgical Research, showing consistent results for the legacy wash-based protocol and encouraging outcomes for an innovative no-wash approach.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.